WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010028859) FACTOR H BINDING PROTEIN IMMUNOGENS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/028859    International Application No.:    PCT/EP2009/006651
Publication Date: 18.03.2010 International Filing Date: 14.09.2009
IPC:
A61K 39/095 (2006.01)
Applicants: NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. [IT/IT]; Via Fiorentina, 1 I-53100 Siena (IT) (For All Designated States Except US).
HUMANITAS MIRASOLE S.P.A. [IT/IT]; Via Manzoni, 56 I-20089 Rozzano (IT) (For All Designated States Except US).
SAVINO, Silvana [IT/IT]; (IT) (For US Only).
DONNELLY, John [IT/IT]; (IT) (For US Only).
RAPPUOLI, Rino [DE/DE]; (DE) (For US Only).
PIZZA, Mariagrazia [IT/IT]; (IT) (For US Only).
BOTTAZZI, Barbara [IT/IT]; (IT) (For US Only)
Inventors: SAVINO, Silvana; (IT).
DONNELLY, John; (IT).
RAPPUOLI, Rino; (DE).
PIZZA, Mariagrazia; (IT).
BOTTAZZI, Barbara; (IT)
Agent: BOTTI, Mario; Botti & Ferrari S.r.l. Via Cappellini, 11 I-20124 Milano (IT)
Priority Data:
MI2008A 001633 12.09.2008 IT
Title (EN) FACTOR H BINDING PROTEIN IMMUNOGENS
(FR) IMMUNOGÈNES DE PROTÉINE DE LIAISON DE FACTEUR H
Abstract: front page image
(EN)The invention relates to immunization against pathogenic bacterial strains which express or can express multiple factor H binding proteins. Certain aspects of the invention include vaccine compositions comprising at least two factor H binding proteins derived from a pathogenic bacterial strain which expresses multiple facto H binding proteins.
(FR)La présente invention concerne l'immunisation contre des souches bactériennes pathogènes qui expriment ou peuvent exprimer des protéines de liaison de facteur H multiples. Certains aspects de l'invention comprennent des compositions de vaccin comprenant au moins deux protéines de liaison de facteur H dérivées à partir d'une souche bactérienne pathogène qui exprime des protéines de liaison de facteur H multiples.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)